Reproducibility of liver stiffness measurements in hepatitis C virus (HCV)-infected patients in Egypt

被引:13
|
作者
Vignier, N. [1 ]
Esmat, G. [2 ,3 ]
Elsharkawy, A. [3 ]
Hassany, M. [2 ]
Bonnard, P. [4 ]
Delarocque-Astagneau, E. [1 ]
Said, M. [5 ]
Raafat, R. [6 ]
El-Hoseiny, M. [6 ]
Fontanet, A. [1 ]
Mohamed, M. K. [6 ,7 ]
Vray, M. [1 ,8 ]
机构
[1] Inst Pasteur, Unite Epidemiol Malad Emergentes, F-75724 Paris 15, France
[2] Natl Hepatol & Trop Med Res Inst, Dept Trop Dis, Cairo, Egypt
[3] Cairo Univ, Dept Trop Med & Hepatol, Fac Med, Cairo, Egypt
[4] Hop Tenon, AP HP, Serv Malad Infectieuses & Trop, F-75970 Paris, France
[5] Kasr El Ainy Hosp, Cairo, Egypt
[6] Ain Shams Univ, Dept Community Environm & Occupat Med, Fac Med, Cairo, Egypt
[7] Natl Hepatol & Trop Med & Res Inst, Viral Hepatitis Reference Lab, Cairo, Egypt
[8] Inst Natl Sante & Rech Med INSERM, Paris, France
关键词
agreement; elastometry; reliability; repeatability; reproducibility; transient elastography; TRANSIENT ELASTOGRAPHY; SIGNIFICANT FIBROSIS; VARIABILITY; ACCURACY; FIBROTEST; DIAGNOSIS; MARKERS; HCV; AGREEMENT; CIRRHOSIS;
D O I
10.1111/j.1365-2893.2010.01433.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Elastometry has demonstrated good accuracy, but little is known about its reproducibility. The aim of this study was to assess the intra- and inter-operator reproducibility of liver stiffness measurement among hepatitis C virus (HCV)-infected patients in Egypt. The study was conducted among HCV-infected patients referred for treatment evaluation in two hepatitis treatment centres of Cairo. Two operators took liver stiffness measurement two times per patient the same day. Intra- and inter-reproducibility were estimated by different methods: Bland and Altman graphics, variation coefficient, intraclass correlation coefficient and Kappa coefficient; 7.1 kPa was used as the threshold of significant (>= F2) fibrosis whenever needed. Fifty-eight patients were included in the study, and 216 measurements were taken. Failure rate was 7% and associated with overweight. For a value of 7.1 kPa, the inter-operator 95% limits of agreement were estimated at +/- 2.88 kPa. Intra-and inter-operator coefficients of variation ranged between 11% and 15%, intraclass correlation coefficients [95% confidence interval] between 0.94 [0.86-0.97] and 0.97 [0.95-0.99], and Kappa coefficients between 0.65 [0.44-0.88] and 0.92 [0.81-1.00]. The reliability of liver stiffness measurement is questionable when considering the decision to initiate antiviral therapy because of the percentage of discordance between measurements is notable, especially in the intermediate fibrosis stages.
引用
收藏
页码:E358 / E365
页数:8
相关论文
共 50 条
  • [41] Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts
    Vargas, HE
    Laskus, T
    Wang, LF
    Lee, R
    Radkowski, M
    Dodson, F
    Fung, JJ
    Rakela, J
    GASTROENTEROLOGY, 1999, 117 (01) : 149 - 153
  • [42] DNA Image Cytometry of the Liver of Chronic Hepatitis C Virus Infected Patients and Hepatocellular Carcinoma in Sharkia Governorate in Egypt
    Samia, M. Sanad
    Amal, M. Mangoud
    Shalaby, Amr A.
    Abd El-Wahed, Mahmoud S.
    LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION, 2011, 8 (04): : 987 - 995
  • [43] Histopathological and Immunohistochemical Studies on the Liver of Chronic Hepatitis C Virus Infected Patients and Hepatocellular Carcinoma in Sharkia Governorate, Egypt
    Samia, M. Sanad
    Amal, M. Mangoud
    Shalaby, Amr A.
    Abd El-Wahed, Mahmoud S.
    LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION, 2011, 8 (04): : 1008 - 1025
  • [44] Role of liver stiffness measurements in patients who develop hepatocellular carcinoma after clearance of the hepatitis C virus
    Yoshinori Gyotoku
    Ryosaku Shirahashi
    Toshikuni Suda
    Masaya Tamano
    Journal of Medical Ultrasonics, 2022, 49 : 253 - 259
  • [45] Role of liver stiffness measurements in patients who develop hepatocellular carcinoma after clearance of the hepatitis C virus
    Gyotoku, Yoshinori
    Shirahashi, Ryosaku
    Suda, Toshikuni
    Tamano, Masaya
    JOURNAL OF MEDICAL ULTRASONICS, 2022, 49 (02) : 253 - 259
  • [46] Sofosbuvir and Ribavirin Liver Pharmacokinetics in Patients Infected with Hepatitis C Virus
    Babusis, Darius
    Curry, Michael P.
    Kirby, Brian
    Park, Yeojin
    Murakami, Eisuke
    Wang, Ting
    Mathias, Anita
    Afdhal, Nezam
    McHutchison, John G.
    Ray, Adrian S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (05)
  • [47] Assessment of stigma among patients infected with hepatitis C virus in Suez City, Egypt
    Soltan E.M.
    Salama H.M.
    Aboelmagd M.A.
    Journal of Public Health, 2018, 26 (3) : 279 - 288
  • [48] Antiviral Treatment for Hepatitis C Virus in HIV/HCV Co-infected Patients
    Ioannou, George N.
    Scott, John D.
    Yang, Yin
    Green, Pamela
    Beste, Lauren A.
    HEPATOLOGY, 2013, 58 : 225A - 225A
  • [49] THE TAKEOVER PHENOMENON IN PATIENTS INFECTED WITH MULTIPLE HEPATITIS-C VIRUS (HCV) GENOTYPES
    OIAN, KP
    NATOV, SN
    PEREIRA, BJG
    LAU, JYN
    HEPATOLOGY, 1995, 22 (04) : 936 - 936
  • [50] Genotyping of hepatitis C virus (HCV) in infected patients from Southern India.
    Poduri, CD
    Khaja, MN
    Madhavi, C
    Hussain, MM
    Farees, N
    Habibullah, CM
    HEPATOLOGY, 2002, 36 (04) : 535A - 535A